CTLA4 and rheumatoid arthritis: Furthermore, CTLA-4Ig administration on RA synovial macrophages and T helper cells downregulated the production of proinflammatory cytokines, and these evidences suggested that CTLA-4 could be a treatment target for RA [62, 63].